In contrast, over-expression of MGAT3 was observed in PBMCs of AD patients treated with curcuminoids (i.e., 7- and 18-fold increase with COMPOUND 1 and 3, respectively). This evidence concerns the gene MGAT3 and Alzheimer disease.